Pearland, TX, United States of America

Ulrich Strych

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: University of Houston System. Active years: 2010.

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 6.0

ph-index = 1


Company Filing History:


Years Active: 2010

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Ulrich Strych: Innovator in Antimycobacterial Compositions

Introduction

Ulrich Strych is a notable inventor based in Pearland, TX (US). He has made significant contributions to the field of antimicrobial research, particularly through his innovative patent related to compositions that exhibit antimycobacterial activity.

Latest Patents

Strych holds a patent titled "Compositions having antimycrobial activity including a hydroxamate or a hydroxamate and a hydroxylamine." This patent discloses antimycorbacterial compositions that comprise at least one hydroxamate or a combination of hydroxamate and hydroxylamine. The preferred ratio of hydroxamate to hydroxylamines is about 100:1 to about 1:1. Additionally, the patent outlines a method for inhibiting mycobacterial growth by administering these compositions to animals, including humans. He has 1 patent to his name.

Career Highlights

Ulrich Strych is affiliated with the University of Houston System, where he continues to engage in research and development in the field of antimicrobial agents. His work has the potential to impact public health significantly by providing new methods to combat mycobacterial infections.

Collaborations

Some of his notable coworkers include Michael Benedik and Myoung Goo Kim, who have collaborated with him on various research projects.

Conclusion

Ulrich Strych's contributions to antimicrobial research through his innovative patent highlight his role as a key inventor in the field. His work not only advances scientific knowledge but also holds promise for improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…